Borgeson Blake (CIK 1856094) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-06). Recent activity: Sell RXRX (30,000 shares), Sell RXRX (40,000 shares), Buy RXRX (88,424 shares), Sell RXRX (30,000 shares), Sell RXRX (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-06 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 30,000 | $97,500 |
| 2026-07-09 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 40,000 | $158,500 |
| 2026-06-22 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 88,424 | $0 |
| 2026-06-04 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 30,000 | $110,400 |
| 2026-05-07 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 30,000 | $105,600 |
| 2026-04-08 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 30,000 | $93,000 |
| 2026-03-04 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 170,000 | $588,200 |
| 2026-02-06 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 220,000 | $924,000 |
| 2026-01-08 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 220,000 | $959,200 |
| 2025-12-04 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Sell | 220,000 | $961,400 |
| 2025-06-23 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 22,016 | $0 |
Source: SEC Form 4 filings · as of 2026-08-06